Director of Cardiac Electrophysiology,Flinders Medical Centre | Head, Cardiac Signals Analysis Lab| Professor of Medicine, Flinders University, Australia
Adelaide
Joined June 2014
- Tweets991
- Following2.1K
- Followers1.8K
- Likes3.5K
Anand Ganesan retweeted
On #WorldHeartDay, Chennai Heart Rhythm Trust (CHRT) conducted a cardiac health awareness drive and provided free health check-up packages for Chennai’s sanitary workers.
Deeply heart-warming as a founding member to give back to those who keep our city running every day. ❤️🩺
Heartfelt thanks to Rotarians Prabhakar, Marshall, and Soundararajan (Rotary Mogappair) and CHRT Secretary Renuga for organizing this wonderful initiative!
HeartHealth #CHRT #Chennai #Rotary
Anand Ganesan retweeted
We will unlock true AF mechanisms in the next few years. Maybe sooner.
AF is fundamentally a problem of nonlinear, multiscale dynamics.
The concept of 10k agents swarming together is impossible to imagine.
We’re sharing a solution to the Navier-Stokes Millennium Prize Problem, one of the deepest problems at the frontier of mathematics.
The proof was produced by a group of agents, using an OpenAI next-generation model significantly more capable than GPT-6 Astra.
The problem concerns whether the description of smooth three-dimensional fluid motion modeled by the Navier-Stokes equations can break down. It has remained unresolved for roughly 90 years.
Anand Ganesan retweeted
It’s all just topology.
Topology, topology, topology, topology, Topology, topology, topology, topology, Topology, topology, topology, topology, Topology, topology, topology, topology..
Please don’t forget this. It’s really important.
Double figure-of-eight reentry during atrial tachycardia using 4 critical boundaries: A unique topological finding #OpenAccess
heartrhythmjournal.com/artic…
Anand Ganesan retweeted
Dr. Joseph Selvanayagam and Dr. C. Michael Gibson discuss the CMR GUIDE trial: Scar-guided ICD implantation did not significantly reduce the primary composite endpoint of SCD/HSVA in patients with LVEF 36-50%. Watch video here: clinicaltrialresults.org/wp-…
Anand Ganesan retweeted
CMR GUIDE trial: Scar-guided ICD therapy did not significantly reduce the primary composite of SCD or HSVA in patients with LVEF 36-50%, despite a signal for reduced SCD. View slides here: clinicaltrialresults.org/wp-…
Anand Ganesan retweeted
It has been an immense privilege to lead this trial, and report on it at @escardio congress. All clinical trials are hard, investigator initiated trials even more so. Thank you to all investigators, trial staff, steering committee, DSMB, CEC and DDC members, and most of all patients and families who took part in the trial
🫀 CMR-GUIDE @ #ESCCongress2026, published in JAMA.
353 pts, LVEF 36–50% + #whyCMR scar, randomized to ICD vs loop recorder.
▪️ Primary endpoint neutral: HR 0.76 (0.37–1.66)
▪️ SCD lower with ICD: 1.7% vs 5.8%
▪️ Prespecified subgroup: benefit in patients <70 @SCMRorg
Anand Ganesan retweeted
How low should we go with BP in atrial fibrillation?
Our #ESC2026 study, simultaneously published in @EuropaceEiC , suggests a “sweet spot”:
🔹 SBP ~120–130 mmHg
🔹 Avoid DBP <75–80 mmHg
🔹 Lower is not always better
In AF, both numbers matter.
bit.ly/4yeNyQB
#AtrialFibrillation #Hypertension
@ElnazShmohamadi @melissaemm1 @Elliott_AD @JonathanAriya
Anand Ganesan retweeted
📊 Research Summary: In patients with left ventricular ejection fraction of 36% to 50% and myocardial scar on #CardiovascularMagneticResonance, implantable cardioverter-defibrillator therapy lowered sudden cardiac death vs an implantable loop recorder, supporting further study of scar-guided device selection. #ESCCongress ja.ma/4hY8PZZ
Anand Ganesan retweeted
💬 Editorial by Sana Al-Khatib, MD, MHS: Current implantable cardioverter-defibrillator recommendations for primary prevention are based on left ventricular ejection fraction of 35% or less, yet many individuals who experience sudden cardiac arrest do not have marked left ventricular dysfunction. Cardiovascular magnetic resonance with late gadolinium enhancement may help identify higher-risk patients with left ventricular ejection fraction >35%, but randomized clinical trial evidence is still needed to guide practice. #ESCCongress ja.ma/46rkWHO
Anand Ganesan retweeted
🧵 Presented today at #ESCCongress from @JAMA_current and @JAMACardio:
In patients with myocardial scar on #CardiovascularMagneticResonance and left ventricular ejection fraction of 36% to 50%, implantable cardioverter-defibrillator therapy lowered sudden cardiac death vs an implantable loop recorder.
🔗 ja.ma/4r1H7Ox
Anand Ganesan retweeted
🧵 Presented at #ESCCongress:
Among patients with ischemic or nonischemic cardiomyopathy, left ventricular ejection fraction of 36% to 50%, and myocardial scar on #CardiovascularMagneticResonance, implantation of an implantable cardioverter-defibrillator did not significantly reduce sudden cardiac death or hemodynamically significant ventricular arrhythmia vs an implantable loop recorder.
Rates of all-cause mortality, cardiovascular mortality, and heart failure–related hospitalization were also similar between groups.
ja.ma/4xClJl2
@escardio
Anand Ganesan retweeted
In patients with myocardial scar on #CardiovascularMagneticResonance and left ventricular ejection fraction of 36% to 50%, implantable cardioverter-defibrillator therapy lowered sudden cardiac death vs an implantable loop recorder. #ESCCongress ja.ma/4qMs4rS
Anand Ganesan retweeted
BREAKING🚨:
I've been awarded a National Heart Foundation Kickstart SA Postdoctoral Fellowship!
Project one is CAPTURE, RCT of live pacing during left bundle branch area pacing versus no pacing.
To celebrate, I built ScrewUp, the game of LBBAP with continuous pacing.
Playable in any browser. Vibe-coded with love.
Thanks to @Vortexium32 , @FlindersUniNews , @SAHeartStroke, @SACVRN for the encouragement and support. Exciting few years to come.
Play ScrewUp here:
u5tnu4slwi.execute-api.ap-so…
Anand Ganesan retweeted
Good morning #EPeeps
#HRS2026
Have you ever wondered about stiffness of PFA vs RFA lesons in the atrium?
👉🏻 Assessment of acute and chronic atrial lesion stiffness after radiofrequency and pulsed field ablation using multifrequency magnetic resonance elastography
@NorupJulie @PrashSanders @MoritzNies @jskoruth @EladAnter @hhuang123 @True_EP
Anand Ganesan retweeted
Thank you so much for the kind words @Alessandrapina_
Congratulations @J_Hendriks1, this year's #HRS Distinguished Allied Professional
Well-deserved is an understatement
Anand Ganesan retweeted
Congratulations @J_Hendriks1, this year's #HRS Distinguished Allied Professional
Well-deserved is an understatement
Anand Ganesan retweeted
Here we go #HRS2026 On the highly touted AVANT GAURD RCT of Boston scientific Farapulse PFA vs AAD. nejm.org/doi/full/10.1056/NE…
The Topline results are positive. Look at that KM curve
But let's look under the hood so as not to be bamboozled
A thread coming and it's quite surprising
Anand Ganesan retweeted
Congrats @drsaurabhkumar RCT VT abl vs AAD CAAD VT at LBCT #HRS2026 @Westmead_EP
Anand Ganesan retweeted
Amazing collaboration to have been involved in the ASCEND CSP study
Full Paper: url.au.m.mimecastprotect.com…
#CHRD @UniofAdelaide @CentralAdlLHN
ASCEND CSP study— The First Stylet-driven ICD lead for LBBP #hrs2026 #LBCT Congratulations Investigators 👏@rdschaller @PrashSanders
Anand Ganesan retweeted
Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial. Read more in EHJ.
doi.org/10.1093/eurheartj/eh…
#CardiacResynchronization #AtrialFibrillation #EHJ #AVNodeAblation #CRT
